COVID-19 Project Team: Difference between revisions

Jump to navigation Jump to search
No edit summary
No edit summary
Line 24: Line 24:
*Muhammad Adnan Haider
*Muhammad Adnan Haider
*[[User:Rinky Agnes Botleroo|Rinky Agnes Botleroo, M.D.]]
*[[User:Rinky Agnes Botleroo|Rinky Agnes Botleroo, M.D.]]
*[[User:Harmeetkharoud91|Harmeet Kharoud]]
* Ongoing Clinical Trials of COVID-19 Team Members
* Ongoing Clinical Trials of COVID-19 Team Members
* Pulmonary Disorders and COVID-19 Team Members
* Pulmonary Disorders and COVID-19 Team Members
Line 34: Line 35:
*[[User:Bosky Soni|Bosky Soni, M.D., MPH]]
*[[User:Bosky Soni|Bosky Soni, M.D., MPH]]
*
*
*[[User:Harmeetkharoud91|Harmeet Kharoud]]
*
*
*
*
*

Revision as of 17:10, 10 June 2020

COVID-19 Project
Introduction
Team
Meetings' Summary
Topics
Ongoing Clinical Trials

Editor-In-Chief: C. Michael Gibson, M.S., M.D. [1]; Associate Editor(s)-in-Chief: Sahar Memar Montazerin, M.D.[2]

Meet The Team

Associate Editor(s)-in-Chief: